Neuroscientific Biopharmaceuticals Ltd. (AU:NSB)
ASX:NSB
Australian Market
Holding AU:NSB?
Track your performance easily

Neuroscientific Biopharmaceuticals Ltd. (NSB) Financial Statements

2 Followers

Neuroscientific Biopharmaceuticals Ltd. Financial Overview

Neuroscientific Biopharmaceuticals Ltd.'s market cap is currently ―. The company's EPS TTM is AU$0.002; its P/E ratio is 17.27; Neuroscientific Biopharmaceuticals Ltd. is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19
Income Statement-
Total Revenue----
Gross Profit----
EBIT----
EBITDA----
Net Income Common Stockholders----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 7.22MAU$ 14.16MAU$ 3.29MAU$ 4.61M
Total AssetsAU$ 7.74MAU$ 14.83MAU$ 3.74MAU$ 5.12M
Total DebtAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -7.22MAU$ -14.16MAU$ -3.29MAU$ -4.61M
Total LiabilitiesAU$ 2.22MAU$ 223.41KAU$ 88.53KAU$ 62.48K
Stockholders EquityAU$ 5.52MAU$ 14.60MAU$ 3.65MAU$ 5.06M
Cash Flow-
Free Cash Flow----
Operating Cash Flow----
Investing Cash Flow----
Financing Cash Flow----
Currency in AUD

Neuroscientific Biopharmaceuticals Ltd. Earnings and Revenue History

Neuroscientific Biopharmaceuticals Ltd. Debt to Assets

Neuroscientific Biopharmaceuticals Ltd. Cash Flow

Neuroscientific Biopharmaceuticals Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis